Pancreatic cancer is currently very difficult to detect while it is still resectable.
Scientists from Lund University found a blood test can detect pancreatic cancer in the very earliest stages of the disease.
The research is published in the Journal of Clinical Oncology and was conducted by Carl Borrebaeck et al.
Due to diffuse symptoms, pancreatic cancer is usually diagnosed very late in the disease progression.
Therefore, despite pancreatic cancer representing less than 3% of all cancer cases, more people currently die from it than breast cancer. By 2030, pancreatic cancer is expected to be the second deadliest type of cancer in the world.
In the study, researchers used samples from patients in both Denmark and the US, at different stages of the disease.
The blood test is developed on a so-called antibody microarray that consists of hundreds of recombinant antibody fragments.
These antibody fragments are specific for a number of immune-regulatory proteins, cancer-associated antigens, and so on.
Since the immune system is the first to respond to threats like complex diseases, such as cancer, autoimmune diseases, and infections, the microarray was designed to mirror this early response.
This provides information about the development of tumors long before being visible on CT or detected by ctDNA. From those hundreds of markers, 29 markers were selected to detect pancreatic cancer with 96% accuracy at stages I and II.
The team found the blood test can detect pancreatic cancer with 96% accuracy at stages I and II, while there is still the possibility of successful surgical intervention.
There is currently no cure and few treatment options for advanced pancreatic cancer, which is the late stage when pancreatic cancer is usually diagnosed.
In the future, the screening method could be used to screen people who are at a higher risk of developing pancreatic cancer, such as those with a hereditary risk, newly onset diabetes patients, and patients with chronic inflammation of the pancreas.
If you care about pancreatic cancer, please read studies about new vaccine that may protect against pancreatic cancer this study shows a new way to kill pancreatic cancer from within.
For more information about pancreatic cancer, please see recent studies about plant compound that may help pancreatic cancer patients and results showing new drug offers hope for people with pancreatic cancer.
Copyright © 2022 Knowridge Science Report. All rights reserved.
